Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free CLSD Stock Alerts $1.41 +0.10 (+7.63%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Clearside Biomedical Short Interest DataCurrent Short Volume224,300 sharesPrevious Short Volume339,900 sharesChange Vs. Previous Month-34.01%Dollar Volume Sold Short$343,179.00Short Interest Ratio / Days to Cover0.6Last Record DateMarch 31, 2024Outstanding Shares74,720,000 sharesPercentage of Shares Shorted0.30%Today's Trading Volume299,006 sharesAverage Trading Volume296,095 sharesToday's Volume Vs. Average101% Short Selling Clearside Biomedical ? Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLSD Short Interest Over TimeCLSD Days to Cover Over TimeCLSD Percentage of Float Shorted Over Time Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Clearside Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53 3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71 2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40 2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22 1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25 1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45 Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17 12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03 11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01 11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96 10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72 10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86 9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87 9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83 8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91 8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99 7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17 7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20 6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12 6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40 5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08 5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07 4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01 4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10 3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04 3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98 2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24 2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34 1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41 1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57 12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12 12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21 11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21 11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41 10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14 10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14 9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13 9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32 8/31/2022468,600 shares $641,982.00 +8.3%1.0%3.1 $1.37 8/15/2022432,700 shares $666,358.00 -7.0%0.9%2.8 $1.54Here’s how to start a “Weekend Side Hustle” from your sofa (Ad)Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.Weekend after weekend! CLSD Short Interest - Frequently Asked Questions What is Clearside Biomedical's current short interest? Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 224,300 shares of CLSD short. Learn More on Clearside Biomedical's current short interest. What is a good short interest ratio for Clearside Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 1.0. Learn More on Clearside Biomedical's short interest ratio. Which institutional investors are shorting Clearside Biomedical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Clearside Biomedical's short interest increasing or decreasing? Clearside Biomedical saw a drop in short interest in March. As of March 31st, there was short interest totaling 224,300 shares, a drop of 34.0% from the previous total of 339,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clearside Biomedical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Clearside Biomedical: Aclaris Therapeutics, Inc. (6.89%), PMV Pharmaceuticals, Inc. (6.40%), Chimerix, Inc. (1.56%), BioXcel Therapeutics, Inc. (10.54%), Eton Pharmaceuticals, Inc. (0.98%), DiaMedica Therapeutics Inc. (0.53%), Oncolytics Biotech Inc. (1.23%), Affimed (1.51%), Hookipa Pharma Inc (0.45%), Allakos Inc. (6.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Clearside Biomedical stock? Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearside Biomedical? A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further. How often is Clearside Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Aclaris Therapeutics Short Squeeze PMV Pharmaceuticals Short Squeeze Chimerix Short Squeeze BioXcel Therapeutics Short Squeeze Eton Pharmaceuticals Short Squeeze DiaMedica Therapeutics Short Squeeze Oncolytics Biotech Short Squeeze Affimed Short Squeeze Hookipa Pharma Short Squeeze Allakos Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLSD) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative